Pulmonary Nodule Detection: Comparison of an Ultra Low Dose vs Standard Scan.

NCT ID: NCT03305978

Last Updated: 2019-08-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-09-26

Study Completion Date

2019-07-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Lung cancer screening programs are still discussed in Europe today, and one of the concern is radiation due to iterative CT. The aim of this monocentric, prospective, non randomized study is to compare an ultra low dose chest CT (approaching a two views X ray) versus a standard low dose chest CT for ≥4mm lung nodules detection, and secondary for lung nodule characterization and smoking associated findings (emphysema, bronchial abnormalities and coronary calcifications).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

An additional Ultra Low Dose CT, approaching 0.2mSv, will be performed in consenting patients referred for non enhanced chest CT in our Revolution CT scanner (GE Healthcare®).The dose delivered with the two acquisitions is still lower than the french diagnostic reference level. Standard CT is interpreted and a report is sent to the referent physician as usual. Then the two acquisitions are read over time by two independent radiologists, blinded over judgment criterias. In case of discordance, an other radiologist will arbitrate. We hope to validate our Ultra low dose chest CT protocol, which is more than 10 times less radiating than a standard low dose CT, as a sensitive tool to detect lung nodules.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Cancer Smoking Radiation Exposure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SEQUENTIAL

Major Patient Addressed for Thoracic CT without Injection of Contrast
Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

SINGLE

Outcome Assessors
blinding evaluation of criteria

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ultra low dose chest CT

Group Type EXPERIMENTAL

Ultra low dose chest CT

Intervention Type DEVICE

An additional ultra low dose CT row is performed for every subject besides standard diagnostic low dose chest CT.

Low dose chest CT

Group Type ACTIVE_COMPARATOR

Low dose chest CT

Intervention Type DEVICE

standard diagnostic low dose chest CT

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ultra low dose chest CT

An additional ultra low dose CT row is performed for every subject besides standard diagnostic low dose chest CT.

Intervention Type DEVICE

Low dose chest CT

standard diagnostic low dose chest CT

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Revolution CT (GE Healthcare) 442507CN0, equiped with ASIR V Revolution CT (GE Healthcare)

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients referred for non enhanced chest CT for following indications :

* lung nodule search or control
* nodular abnormality on chest X ray
* statement of COPD or emphysema
* asbestos exposure
* nodule localization before radio frequency ablation
* assessment of disease extent of an extra thoracic cancer (in case of iodinated intravenous contrast agent contraindication)
* statement before extrathoracic transplantation (in case of iodinated intravenous contrast agent contraindication)
2. Affiliated with the french social security
3. Who signed consent

Exclusion Criteria

1. Inability to lie down and still during the examination
2. Inability to hold breath more than 5 seconds
3. Pneumonia in the last 3 months
4. Body mass index more than 35kg/m²
5. exclusion period of another interventionnal study
6. referred for articles L1121-5 to L1121-8 of french public health code
7. Pregnant or breastfeeding women
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Grenoble

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gilbert Ferretti, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Grenoble

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital Grenoble

Grenoble, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Ludwig M, Chipon E, Cohen J, Reymond E, Medici M, Cole A, Moreau Gaudry A, Ferretti G. Detection of pulmonary nodules: a clinical study protocol to compare ultra-low dose chest CT and standard low-dose CT using ASIR-V. BMJ Open. 2019 Aug 15;9(8):e025661. doi: 10.1136/bmjopen-2018-025661.

Reference Type DERIVED
PMID: 31420379 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

38RC17.132

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

PET-CT in Lymphoma Among the Eldery
NCT07259941 NOT_YET_RECRUITING